BSI Application_Kevin James_Entos_AlbertaSoB

Entos Pharmaceuticals (Entos) is an Edmonton-based company that has developed a novel DNA-based vaccine against COVID-19, called Covigenix. Covigenix, is a pan coronavirus vaccine that is being rapidly deployed using Entos’ patented Fusogenix technology. The role of the MBA intern will be to work with Entos’ Regulatory and Business Development teams to develop and execute a Quality and Chemical, Manufacturing, and Chemistry (CMC) strategy that will enable the Covigenix vaccine to meet all regulatory approvals.

Faculty Supervisor:

Michael Maier

Student:

Partner:

Entos Pharmaceuticals

Discipline:

Business

Sector:

Professional, scientific and technical services

University:

University of Alberta

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects